Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amir Mohammad Shabani"'
Autor:
Ahmad Alikhani, Zahra Nekoukar, Minoo Moghimi, Maysam Rezapour, Seyyed Javad Boskabadi, Amir Mohammad Shabani, Hamideh Abbaspour Kasgari
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 32, Iss 215, Pp 163-168 (2022)
Background and purpose: Tocilizumab (TCZ), a monoclonal antibody against interleukin-6 (IL-6) receptor, is emerged as an alternative treatment for COVID-19 patients with a risk of cytokine storms. This study aimed at investigating the efficacy of TCZ
Externí odkaz:
https://doaj.org/article/2375a79d313649439bacab1ec3c2d7a2
Autor:
Hamideh Abbaspour Kasgari, Siavash Moradi, Farhang Babamahmoodi, Amir Mohammad Shabani, Lotfollah Davoodi, Alireza Davoudi Badabi
Publikováno v:
Pharmaceutical and Biomedical Research, Vol 8, Iss 1, Pp 31-42 (2022)
Background: Lymphopenia is an important but nonspecific laboratory indicator of COVID-19. Objectives: To describe epidemiologic and clinical characteristics of the first cases of the COVID-19 referred to a center dedicated to COVID-19 patients in Ira
Externí odkaz:
https://doaj.org/article/e9db2530b53b4d909c28b22aec091144
Autor:
Atefeh Bonyadi, Fariborz Mansour-Ghanaei, Farhang Babamahmoodi, Esmat Radmanesh, Hadiseh Hosamirudsari, Javad Khodadadi, Sara Sayar, Zeinab Mehrabi, Amir Reza Bahadori, Shahin Merat, Minoo Moghimi, Gholamali Eslami, Hashem Mousavi, Lotfollah Davoodi, Mona Ebrahimzadeh, Farahnaz Joukar, Amir Anushiravani, Ali Ali Asgari, Ali Reza Davoudi Badabi, Elham Barahimi, Saeed Jelvay, Zahra Poormontaseri, Aida Zeinali, Nasim Khajavirad, Minoosh Shabani, Hamideh Abbaspour Kasgari, Zohreh Azarkar, Rohollah Moslemi, Ahmad Hormati, Azadeh Ebrahimzadeh, Hani Esmaeilian, Shokrollah Salmanzadeh, Elham Akbarpour, Lili Rezaie Keikhaie, Kaitlyn McCann, Amir Mohammad Shabani, Abdolali Tousi, Mohammad Abdollahi, Sara Mobarak, Mohammadreza Naghipour, Hadi Mirzaei, Mohammadreza Salehi, Shervin Shokouhi, Bryony Simmons, Morteza Mobarak, Helia Nateghi Baygi, Jacob Levi, Mehdi Hassaniazad, Andrew Hill, Zahra Arizavi, Nasrollah Hasooni Bahrini, Seyed Ali Dehghan Manshadi, Fatemeh Dehghani, Hannah Wentzel, Hossein Pourmasoomi, Masoome Noori Jangi, Shoeleh Yaghoubi, Alireza Nateghi Baygi, Mehdi Salasi, Farnaz Zolfaghari, Sara Yeganeh, Elmira Azimi, Jalal Karimi, Hafez Fakheri, Mahdi Afshari, Tofigh Yaghubi Kalurazi, Anahita Sadeghi, Farshid Abedi, Sajedeh Mousaviasl, Zahra Nekoukar, Dorsa Merat, Masood Ziaee
Publikováno v:
Journal of Antimicrobial Chemotherapy
Background: The combination of sofosbuvir (SOF) and daclatasvir (DCV) has shown preliminary efficacy for patients with COVID-19 in five open-label studies with small sample sizes. This larger trial aimed to assess if the addition of sofosbuvir and da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f69baf1a0987326edb8a47d694d9afe2
https://doi.org/10.1093/jac/dkab433
https://doi.org/10.1093/jac/dkab433
Autor:
Zahra, Nekoukar, Shahram, Ala, Siavash, Moradi, Andrew, Hill, Ali Reza, Davoudi Badabi, Ahmad, Alikhani, Shahriar, Alian, Minoo, Moghimi, Amir Mohammad, Shabani, Hamideh, Abbaspour Kasgari
Publikováno v:
Iranian journal of pharmaceutical research : IJPR. 20(4)
This was a randomized, double-blind clinical trial to compare the efficacy and safety of Atazanavir/Ritonavir (ATZ/RTV) with Lopinavir/Ritonavir (LPV/RTV) in moderate Coronavirus disease 2019 (COVID-19). Participants were randomly assigned to receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee0fc4e065d1e94eb0c89acd5c2ebabc
https://pubmed.ncbi.nlm.nih.gov/35194446
https://pubmed.ncbi.nlm.nih.gov/35194446
Publikováno v:
Pharmaceutical and Biomedical Research.
Background: Various digestive symptoms have been frequently reported in a significant portion of patients infected with the virus since the outbreak of Coronavirus Disease 2019 (COVID-19). Most patients with COVID-19 have a fever accompanied by respi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7702d3b122fb8ee7c5222ef3bbf812e7
https://doi.org/10.18502/pbr.v7i2.7366
https://doi.org/10.18502/pbr.v7i2.7366